Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 47% ± 12% | |
lung | 15 studies | 35% ± 13% | |
intestine | 8 studies | 26% ± 8% | |
bone marrow | 5 studies | 27% ± 11% | |
liver | 4 studies | 27% ± 11% | |
lymph node | 4 studies | 34% ± 15% | |
brain | 4 studies | 32% ± 17% | |
kidney | 3 studies | 29% ± 8% | |
adipose | 3 studies | 30% ± 9% | |
placenta | 3 studies | 25% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 10432.23 | 576 / 578 | 96% | 167.31 | 1105 / 1155 |
breast | 93% | 2479.69 | 428 / 459 | 92% | 89.19 | 1027 / 1118 |
intestine | 81% | 5906.38 | 780 / 966 | 98% | 177.86 | 519 / 527 |
stomach | 78% | 2106.45 | 279 / 359 | 99% | 170.51 | 282 / 286 |
thymus | 67% | 1290.17 | 439 / 653 | 95% | 107.55 | 574 / 605 |
bladder | 71% | 2025.71 | 15 / 21 | 90% | 118.94 | 453 / 504 |
liver | 73% | 1559.33 | 164 / 226 | 81% | 72.09 | 327 / 406 |
esophagus | 63% | 1147.73 | 905 / 1445 | 82% | 90.54 | 150 / 183 |
kidney | 38% | 817.09 | 34 / 89 | 86% | 112.25 | 773 / 901 |
pancreas | 27% | 540.67 | 88 / 328 | 93% | 157.67 | 166 / 178 |
adrenal gland | 79% | 1841.68 | 204 / 258 | 36% | 18.29 | 83 / 230 |
prostate | 55% | 947.36 | 135 / 245 | 51% | 24.53 | 256 / 502 |
uterus | 24% | 336.23 | 40 / 170 | 80% | 77.11 | 365 / 459 |
skin | 21% | 282.72 | 372 / 1809 | 81% | 97.94 | 383 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 447.52 | 29 / 29 |
peripheral blood | 100% | 35516.86 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 18677.59 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 4481.25 | 1192 / 1204 | 0% | 0 | 0 / 0 |
ovary | 19% | 292.46 | 34 / 180 | 73% | 46.84 | 312 / 430 |
tonsil | 0% | 0 | 0 / 0 | 87% | 97.97 | 39 / 45 |
brain | 18% | 337.06 | 468 / 2642 | 61% | 41.81 | 429 / 705 |
blood vessel | 61% | 1763.57 | 812 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 35% | 21.89 | 28 / 80 |
heart | 27% | 434.99 | 229 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 17.34 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_2001259 | Biological process | positive regulation of cation channel activity |
GO_0097067 | Biological process | cellular response to thyroid hormone stimulus |
GO_0016485 | Biological process | protein processing |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0030574 | Biological process | collagen catabolic process |
GO_0010447 | Biological process | response to acidic pH |
GO_0048002 | Biological process | antigen processing and presentation of peptide antigen |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0006508 | Biological process | proteolysis |
GO_0010952 | Biological process | positive regulation of peptidase activity |
GO_0019886 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO_0006915 | Biological process | apoptotic process |
GO_0019882 | Biological process | antigen processing and presentation |
GO_0034769 | Biological process | basement membrane disassembly |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005764 | Cellular component | lysosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005770 | Cellular component | late endosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0036021 | Cellular component | endolysosome lumen |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0001968 | Molecular function | fibronectin binding |
GO_0043236 | Molecular function | laminin binding |
GO_0043394 | Molecular function | proteoglycan binding |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005518 | Molecular function | collagen binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | CTSS |
Protein name | Cathepsin S Cathepsin S (EC 3.4.22.27) |
Synonyms | hCG_39378 |
Description | FUNCTION: Thiol protease. Key protease responsible for the removal of the invariant chain from MHC class II molecules and MHC class II antigen presentation . The bond-specificity of this proteinase is in part similar to the specificities of cathepsin L. . |
Accessions | A0A7P0T8A1 A0A7P0T8U1 ENST00000680664.1 ENST00000679582.1 ENST00000680288.1 [P25774-2] ENST00000681728.1 A0A7P0TB77 ENST00000680471.1 A0A7P0T7Z6 U3KQE7 ENST00000680931.1 U3KPS4 ENST00000607427.2 [P25774-1] ENST00000472977.7 [P25774-1] ENST00000681444.1 [P25774-1] ENST00000679898.1 ENST00000679512.1 ENST00000483930.2 A0A7P0TAQ0 P25774 ENST00000472977 A0A7P0T904 ENST00000448301.7 ENST00000680311.1 A0A7P0T8H4 A0A804DAZ0 ENST00000368985.8 [P25774-1] A0A7P0T844 |